Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-α

World Journal of Gastroenterology

Volumn 11, Issue 1, 2005, Pages 122-126

  Wu, Chun Song ^a   Piao, Xi Xu ^a   Piao, Dong Ming ^a   Jin, Yong Ri ^a   Li, Cheng Hao ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

Boschniakia rossica; Interferon alpha; Liver fibrosis; Oxymatrine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ALPHA1 INTERFERON; BOSCHNIAKIA ROSSICA EXTRACT; COLLAGEN TYPE 4; MESSENGER RNA; OXYMATRINE; PLANT EXTRACT; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOSCHNIAKIA ROSSICA; CHINESE HERB; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER TOXICITY; LIVER WEIGHT; MALE; MEDICINAL PLANT; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; SWINE;

EID: 11844279044     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i1.122     Document Type: Article

References (30)

1. Cai WM. Medicinal therapy of anti-fibrosis. Zhonghua Ganzhangbing Zazhi 2001; 4: 120-121
2. Wang BE. Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol 2000; 15 Suppl): E67-70
3. Yin ZZ, Kim HS, Kim YH, Lee JJ. Iridoid compounds from Boschniakia rossica. Arch Pharm Res 1999; 22: 78-80
4. Yu QH, Gao DY, Piao GC, Shun QS, Yang HJ, Niu YF, Liu YJ. The experimental pharmacology study of Boschniakia rossica. Zhongyaocai 1993; 16: 32-34
5. Tusda T, Liu YZ, Sugaya A, Katoh K, Hori K, Tanaka S, Nomura M, Sugaya E. Reinfocement effects of Boschniakia rossica on discrimination learning in cholinergic lesions of rats. J Ethnopharmacol 1994; 44: 67-71
6. Tsuda T, Sugaya A, Liu YZ, Katoh K, Tanaka H, Kawazura H, Sugaya E, Kusai M, Kohno M. Radical scavenger effect of Boschniakia rossica. J Ethnopharmacol 1994; 41: 85-90
7. Yang WZ, Zeng MD, Lu LG, Mao YM, Fan ZP, Song YL, Jia YT, Chen CW, Pen YS, Zhu HY. An experimental study of prophylactic effect of Oxymatrine on D-galactosamine-induced rat liver fibrosis. Ganzang 2002; 7: 2-4
8. Song J, Zhang XR, Zhu L, Zhang ZB, Zhang XK. Effects of Oxymatrine on the proliferation and procollagen III mRNA expression. Dier Junyi Daxue Xuebao 1999; 20: 356-358
9. Chen C, Liu B, Gu YH, Ge SM. Inhibition of oxymatrine, a Chinese herbal medicine, and Chinese made interferon-alpha1b andalpha2b on proliferation and collagen synthesis of rat hepatic stellate cells. Weichangbingxue He Ganbingxue Zazhi 2002; 3: 32-35
10. Yang W, Zeng M, Fan Z, Mao Y, Song Y, Jia Y, Lu L, Chen CW, Peng YS, Zhu HY. Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis. Zhonghua Ganzangbing Zazhi 2002; 10: 193-196
11. Yu YY, Wang QH, Zhu LM, Zhang QB, Xu DZ, Guo YB, Wang CQ, Guo SH, Zhou XQ, Zhang LX. A clinical research on oxymatrine for the treatment of chronic hepatitis B. Zhonghua Ganzangbing Zazhi 2002; 10: 280-281
12. Zhai WR, Wang TL, Zhou XJ, Zhang TH. The diagnosis, grading and staging of chronic hepatitis. Zhonghua Xiaohua Zazhi 1996; 16: 277-280
13. Piao YR, Jiang YS, Li YX, Jin MS, Jiang YN. Effects of Boschniakia rossica on the immune reactivation of hepatic kuffle cells. Zhongcaoyao 1994; 25: 200-202
14. Yang XW, Lou ZC, Yan ZK. Anti-lipid peroxidative effects of ethanolic extract of Boschniakia rossica on the liver tissue of mice in vivo. Zhongguo Yaoxue Zazhi 1995; 30: 84-86
15. Shen M, Yin Z. Effect of Boschniakia rossica extract on antioxidative activities in rat hepatic preneoplasia induced bu diethylnitrosamine. Zhongguo Zhongyao Zazhi 1999; 24: 746-748
16. ras proteins in early stage of chemical hepatocarcinogenesis and its anti-inflammatory activities in rats. World J Gastroenterol 2000; 6: 812-818
17. Lu G, Shimizu I, Cui X, Itonaga M, Tamaki K, Fukuno H, Inoue H, Honda H, Ito S. Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells. J Med Invest 2002; 49: 172-181
18. Zhang Q, Wang J, Hu M. Effects of interferon-alpha on the mRNA expression of procollagen type I and III of hepatic stellate cells and on the deposition of collagen type I and III in fibrotic liver of rats. Zhonghua Yixue Zazhi 1999; 79: 695-698
19. Muriel P, Bolanos J, Barral JM, Torres G. Effect of alpha-interferon on erythrocyte and hepatocyte plasma membranes derived from cirrhotic rats. Pharmacology 1994; 48: 63-68
20. Fort J, Pilette C, Veal N, Oberti F, Gallois Y, Douay O, Rosenbaum J, Cales P. Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats. J Hepatol 1998; 29: 263-270
21. Ninomiya T, Yoon S, Nagano H, Kumon Y, Seo Y, Kasuga M, Yano Y, Nakaji M, Hayashi Y. Significance of serum matrix metalloproteinases and their inhibitors on the antifibrogenetic effect of interferon-alfa in chronic hepatitis C patients. Intervirology 2001; 44: 227-231
22. Jarmay K, Gallai M, Karacsony G, Ozsvar Z, Schaff Z, Lonovics J, Kovalszky I. Decorin and actin expression and distribution in patients with chronic hepatitis C following interferon- alfa-2b treatment. J Hepatol 2000; 32: 993-1002
23. Serejo F, Costa A, Oliveira AG, Ramalho F, Batista A, De Moura MC. Alpha-interferon improves liver fibrosis in chronic hepatitis C: Clinical significance of the serum N-terminal propeptide of procollagen type III. Dig Dis Sci 2001; 46: 1684-1689
24. Vendemiale G, Grattagliano I, Caruso ML, Serviddio G, Valentini AM, Pirrelli M, Altomare E. Increased oxidative stress in dimethylnitrosamine- induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-alpha. Toxicol Appl Pharmacol 2001; 175: 130-139
25. Mazzoran L, Tamaro G, Mangiarotti MA, Marchi P, Baracetti S, Gerini U, Fanni-Cannelles M, Zorat F, Pozzato G. Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease. Eur J Gastroenterol Hepatol 1998; 10: 125-131
26. Cheng ML. The basically study and clinic of liver fibrosis. BeiJing: people's Medical Publishinghouse of China 1996: 17-50
27. 1 expression in pig serum-induced rat liver fibrosis in vivo. Hepatology 1998; 28: 471-479
28. Zhan YT, Wei HS. The effect and sence of transferming growth factor-β inliver fibrosis. Guowai Yixue Mianyixue Fence 2000; 24: 230-233
29. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, zum Buschenfelde KH, Blessing M. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999; 276(4 Pt 1): G1059-G1068
30. Wang BE. Hepatic stellate cell and liver fibrosis. Zhonghua Ganzhangbing Zazhi 2000; 8: 197-199